Latest News

Cannabis stocks increase ahead of possible Trump order to relax marijuana restrictions

Stocks of cannabis companies rose on Thursday in premarket trading, fueled by expectations that U.S. president Donald Trump will sign an executive order easing federal regulations on marijuana.

The debate about marijuana regulation is dominated by calls to reclassify marijuana as a safer drug. This would be the "most significant" change in marijuana policy ever since 1970.

This reclassification would not legalize marijuana, but it could reduce tax burdens on firms, speed up research, allow for standard drug development, and improve access to capital.

Tilray shares listed in the U.S. gained?nearly 5%. SNDL rose 3%. Canopy grew more than 5%. AdvisorShares Pure US Cannabis ETF rose 6.5%.

Reclassification of marijuana would shift it from Schedule I (which includes substances like heroin, ecstasy, and peyote) that are not accepted for medical purposes to Schedule?III which covers substances with a moderate or low?risk?of physical or psychological dependency.

According to reports, Trump is considering a Medicare Pilot Program?that could provide seniors with?access CBD.

Rearranging Medicare coverage and attracting investments from other investors and financial institutions would be likely.

(source: Reuters)